Ipilimumab +Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma

Condition:   Soft Tissue Sarcoma Interventions:   Drug: Ipilimumab;   Procedure: Cryoablation;   Drug: Nivolumab Sponsors:   Stanford University;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

Condition:   Soft Tissue Sarcoma Interventions:   Drug: Ipilimumab;   Procedure: Cryoablation;   Drug: Nivolumab Sponsors:   Stanford University;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
AbstractSarcoma is rare and heterogenous with various subtypes having a different prognostic. Desmoid is a tumour with a local aggressiveness; GIST with KIT mutation responds massively to target treatment as IMATINIB, whereas soft tissue sarcoma and leiomyosarcoma are very aggressive with poor response to systemic therapies. Interventional radiology plays an important role in the diagnosis of sarcomas with image-guided percutaneous core needle biopsy being the most commonly used biopsy technique in the diagnosis of sarcomas. Biopsy access routes discussed with the surgeon, and skin access is tattooed. Surgery is a mainstay...
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
More News: Cryotherapy | Research | Sarcomas | Soft Tissue Sarcoma | Yervoy